Skip to main content
. Author manuscript; available in PMC: 2013 Jul 6.
Published in final edited form as: Clin Cancer Res. 2010 Jun 10;16(15):4038–4045. doi: 10.1158/1078-0432.CCR-10-0822

Fig. 2.

Fig. 2

Cmax, AUC, and CNS adverse events (AEs) in patients receiving 28 mg/m2. A, Cmax and CNS adverse events in patients receiving 28 mg/m2. B, AUC and CNS adverse events in patients receiving 28 mg/m2.